Literature DB >> 7530671

Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies.

J C Duclos-Vallée1, O Hajoui, A M Yamamoto, E Jacz-Aigrain, F Alvarez.   

Abstract

BACKGROUND/AIMS: Four linear antigenic sites have been shown on the CYP2D6 molecule that are recognized by serum positive for liver/kidney microsomal antibody (LKM) type 1. The aim of this study was to search for antibodies against CYP2D6 conformational antigenic sites in LKM-1-positive sera.
METHODS: The capacity of four LKM-1-positive sera, before and after absorption with synthetic peptides representing CYP2D6 linear antigenic sites, and rabbit sera against linear antigenic sites between CYP2D6 amino acids 254-271 and 373-389 to inhibit the O-demethylation of dextromethorphan by CYP2D6 was tested in vitro.
RESULTS: Inhibition of O-demethylation of dextromethorphan was not modified by absorption of antibodies against linear CYP2D6 antigenic sites. In addition, rabbit sera against two of these sites did not inhibit the reaction. These results strongly suggest that antibodies against CYP2D6 conformational antigenic sites were present in LKM-1-positive sera.
CONCLUSIONS: The autoimmune response against CYP2D6 is directed against linear and conformational antigenic sites. These results strengthen the argument that the LKM-1 response is polyclonal and antigen driven.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530671     DOI: 10.1016/0016-5085(95)90076-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

3.  Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.

Authors:  R Klein; U M Zanger; T Berg; U Hopf; P A Berg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 4.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 5.  Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.

Authors:  P Obermayer-Straub; M P Manns
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

6.  Argininosuccinate lyase: a new autoantigen in liver disease.

Authors:  N Pelli; A H Fensom; C Slade; F Boa; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

Review 8.  The role of vitamin d in autoimmune hepatitis.

Authors:  Khanh Vinh Quoc Luong; Lan Thi Hoang Nguyen
Journal:  J Clin Med Res       Date:  2013-10-12

Review 9.  Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.

Authors:  Marcial Sebode; Christina Weiler-Normann; Timur Liwinski; Christoph Schramm
Journal:  Front Immunol       Date:  2018-03-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.